Evaluating the biological characteristics of targeted ZIF-8-encapsulated individual and combined drug systems for enhanced in vivo toxicity mitigation using folic acid ligands
Abstract
) with significant improved survivability (90%) until 120 h of incubation. Results showed that RuPIP-Olap@ZIF8-FA did not cause significant malformations, even at elevated concentrations, and did not present aggregation issues toward healthy embryos. These findings establish RuPIP-Olap@ZIF-8-FA as a promising dual-drug nanocarrier capable of targeted delivery, pH-triggered release, and distinct therapeutic pathways. Its high loading efficiency, simplicity, and improved safety profile highlight its strong potential for advancement toward clinical translation.
Fields of Study & Subjects
Metal-Organic Frameworks: Synthesis and Applications
Nanoparticle-Based Drug Delivery
Graphene and Nanomaterials Applications
Publication details
- Journal / source
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 16
- Issue
- 2
- Pages
- 1912–1931
- Publication date
- 1 January 2026
- Language
- EN